Escitalopram
Indication
Generalised anxiety disorder
MHRA Drug Safety Update - Citalopram and escitalopram: QT interval prolongation
*FOR FYLDE & WYRE CCG ONLY* - Consultant initiated, only after Sertraline tried.
Green
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Central nervous system
Background
LSCMMG is adopting the local decision made prior to April 2013
The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.
Recommendation
LSCMMG Recommendation:
Green
Reason for decision:
Suitable for initiation in primary care
Supporting documents: